# Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity: A Prospective Interventional Case Series

> **NCT07721298** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 39 (actual)

## Conditions studied

- Retinopathy of Prematurity (ROP)

## Interventions

- **DRUG:** Intravitreal Ranibizumab injection

## Key facts

- **NCT ID:** NCT07721298
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-10
- **Primary completion:** 2024-09-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07721298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07721298, "Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity: A Prospective Interventional Case Series". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07721298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*